Uncategorized

Clearside Biomedical, Inc. to Present at the 13th Congress of International Ocular Inflammation Society (IOIS) in San Francisco, CA

by Business Wire • 2015/09/22 • 0 Comments

ALPHARETTA, Ga.--(BUSINESS WIRE)--Clearside Biomedical, which develops drug therapies to treat diseases of the eye, to present at the International Ocular Inflammation Society meeting Sept. 25-27, 2015, in San Francisco.

Full Story →

← Woman presents with bilateral progressive ptosis

Research and Markets: Dry Eye Syndrome Forecast in 7 Major Markets 2015-2025 – USA, France, Germany, Italy, Spain, UK and Japan →

Post navigation